Contents

Search


transfusion-associated infection

Pathology: 1) viral transmission a) etiology: failure to recognize asymptomatic donors infected with HIV-1, HIV-2, HTLV-1, HTLV-2, hepatitis viruses, CMV, & others b) clinical manifestations: related to transmitted virus c) incidence: (risk per unit of component transfused) - HIV: < 1 in 200,000 - hepatitis B: < 1 in 200,000 - hepatitis C: < 1 in 3000 - HTLV: < 1 in 60,000 - CMV: 50-100% of donors are infected d) prevention: 1] careful donor screening 2] serologic testing 3] leukocyte filters to remove strictly leukocyte- associated viruses (HTLV) 4] donors negative for antibodies to CMV less likely to transmit CMV 2) transmission of bacteria & bacterial endotoxins a) etiology: 1] unrecognized bacteremia in donor 2] contamination during processing 3] bacterial contamination of donor platelets is the most common cause 4] E. coli & Pseudomonas are associated with refrigerated components 5] Yersinia, Serratia & Salmonella are associated with platelets b) clinical manifestations: 1] shock & disseminated intravascular coagulation (DIC) 2] high mortality c) incidence: < 1 in 500,000 as cause of death d) prevention: 1] proper skin preparation with blood donation 2] good blood banking practices 3] deferring donors with febrile illnesses 4] use of leukocyte-depleted blood components 3) transmission of parasites a) etiology: donors infected with parasites, i.e. Plasmodium (malaria), Trypanosomes (Chagas' disease) b) clinical manifestations: related to transmitted parasite c) incidence: rare in the USA d) prevention: 1] donor screening 2] development of serologic tests

Specific

transfusion-associated bacterial infection transfusion-associated viral infection

General

complication infection (infectious disease)